Gray Matter Volume Correlates of Co-Occurring Depression in Autism Spectrum Disorder.

Researchers used brain scans to study depression in 44 adults with autism. They found that people with more severe depression had less brain tissue (grey matter) in a specific brain region called the thalamus. They also discovered that depression and autism symptoms together affected brain tissue in the cerebellum, a brain area involved in movement and thinking. This research helps us better understand how depression affects the autistic brain and could lead to better ways to identify and treat depression in autistic people.

This neuroimaging study examined brain structure differences associated with co-occurring depression in 44 adults with autism spectrum disorder (ASD) aged 17-28 years, using MRI data from the ABIDE II repository. Researchers investigated regional grey matter volume (rGMV) patterns in relation to depression severity and autism symptoms. Key findings revealed that depression severity correlated negatively with grey matter volume in the right thalamus. Additionally, an interaction between depression severity and core ASD symptoms was observed in explaining grey matter volume in the left cerebellum crus II.

The study also included exploratory comparisons with 39 typically developed controls. These findings advance understanding of the neurobiological basis of co-occurring depression in autism and may inform development of neuroimaging-based biomarkers for this population.

Findings suggest potential for neuroimaging biomarkers to identify co-occurring depression in autism, which often goes undiagnosed. The thalamus and cerebellum may be important targets for understanding depression in autistic individuals. Results highlight need for improved depression screening and assessment tools specifically designed for the autism population.

Small sample size (n=44) limits generalizability. Cross-sectional design prevents causal inferences. Exploratory nature of some analyses requires replication. Limited age range (17-28 years) restricts applicability across lifespan. Challenges in depression assessment in autism population acknowledged but specific measurement limitations unclear.

Autism Spectrum Disorder (ASD) involves neurodevelopmental syndromes with significant deficits in communication, motor behaviors, emotional and social comprehension. Often, individuals with ASD exhibit co-occurring depression characterized by a change in mood and diminished interest in previously enjoyable activities. Due to communicative challenges and a lack of appropriate assessments in this cohort, co-occurring depression can often go undiagnosed during routine clinical examinations and, thus, its management neglected. The literature on co-occurring depression in adults with ASD is limited.

Therefore, understanding the neural basis of the co-occurring psychopathology of depression in ASD is crucial for identifying brain-based markers for its timely and effective management. Using structural MRI and phenotypic data from the Autism Brain Imaging Data Exchange (ABIDE II) repository, we examined the pattern of relationship regional grey matter volume (rGMV) has with co-occurring depression and autism severity within regions of a priori interest in adults with ASD (n = 44; age = 17-28 years). Further, we performed an exploratory analysis of the rGMV differences between ASD and matched typically developed (TD, n = 39; age = 18-31 years) samples. The severity of co-occurring depression correlated negatively with the rGMV of the right thalamus.

Additionally, a significant interaction was evident between the severity of co-occurring depression and core ASD symptoms towards explaining the rGMV in the left cerebellum crus II. The results further the understanding of the neurobiological underpinnings of co-occurring depression in adults with ASD towards exploring neuroimaging-based biomarkers in the same cohort.